Linagliptin's Effect on CD34+ Stem Cells

Clinical trial NCT02467478 · COMPLETED

Trial details

NCT number: NCT02467478
Sponsor: George Washington University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Impaired Renal Function

Start date: 2015-04-01
Primary completion: 2019-04-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.